BCL9L anticorps (AA 606-751)
-
- Antigène Voir toutes BCL9L Anticorps
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Épitope
- AA 606-751
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp BCL9L est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunohistochemistry (IHC), Neutralization (Neut)
- Purification
- purified
- Immunogène
- Purified recombinant fragment of human BCL9L (AA: 606-751) expressed in E. coli.
- Clone
- 1C9G2
- Isotype
- IgG1
-
-
- Indications d'application
- ELISA: 1:10000, WB: 1:500 - 1:2000, ICC: N/A, FCM: 1:200 - 1:400, IHC: N/A
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- 4°C, -20°C for long term storage
-
- Antigène
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
- Autre désignation
- BCL9L (BCL9L Produits)
- Synonymes
- anticorps BCL9-2, anticorps DLNB11, anticorps B9L, anticorps BC003321, anticorps bcl9-2, anticorps BCL9L, anticorps B-cell CLL/lymphoma 9 like, anticorps B cell CLL/lymphoma 9-like, anticorps B-cell CLL/lymphoma 9-like, anticorps BCL9L, anticorps Bcl9l, anticorps bcl9l
- Sujet
-
Description: BCL9L (B-Cell CLL/Lymphoma 9-Like) is a Protein Coding gene. Among its related pathways are Wnt Signaling Pathways: beta-Catenin-dependent Wnt Signaling and Signaling by Wnt. GO annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.
Aliases: BCL9-2, DLNB11
- Poids moléculaire
- 157 kDa
- ID gène
- 283149
- HGNC
- 283149
- Pathways
- Stem Cell Maintenance
-